Statistics
Publications
8
Citations
379
H-Index
8
Active since
2019
Rhiannon Morris is an author at The University of Melbourne specializing in life sciences, signal transduction, and cancer genetics.
Publications per year
2019–2024
8
8
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
Donia M. Moujalled, Fiona C. Brown, Chong Chyn Chua et al. · Blood · 2022 · 102 citations · Full text
Medicine, Oncology, Pharmacology +16
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
Sarah T. Diepstraten, John E. La Marca, Savannah Young et al. · Cancer Cell · 2024 · 47 citations · Full text
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
Nicholas P. D. Liau, Artem Laktyushin, Rhiannon Morris et al. · Cancers · 2019 · 20 citations · Full text
<i>TP53</i> status and impact on AML prognosis within the ELN 2022 risk classification
Shaun Fleming, Rhiannon Morris, Hsin‐An Hou et al. · Blood · 2023 · 17 citations · Full text
1–5 of 8